Clinical Trial Update: Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a gonadotropin-releasing hormone antagonist for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GnRH antagonist therapy (gonadotropin-releasing hormone antagonist)

Snippet

Sponsor: Betanien Hospital | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED